Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 1.00 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.85 |
| ▸ | MEN1 | O00255 | 3/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.74 |
| ▸ | PKM | P14618 | 1/20 | 0.74 |
| ▸ | IL1RN | P18510 | 1/20 | 0.73 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.73 |
| ▸ | HTR6 | P50406 | 3/20 | 0.71 |
| ▸ | CA2 | P00918 | 5/20 | 0.70 |
| ▸ | CA1 | P00915 | 4/20 | 0.70 |
| ▸ | CA9 | Q16790 | 4/20 | 0.70 |
| ▸ | HTT | P42858 | 1/20 | 0.70 |
| ▸ | CA12 | O43570 | 3/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | TMPRSS6 | Q8IU80 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3081180 | 0.92 | KEAP1 (1.00) | KMT2AKEAP1MEN1ALDH1A1PKM | |
| SCHEMBL11793140 | 0.90 | CA1 (0.85) | KMT2AKEAP1MEN1ALDH1A1PKM | |
| SCHEMBL540915 | 0.90 | CA1 (0.85) | KMT2AKEAP1MEN1ALDH1A1PKM | |
| SCHEMBL9001182 | 0.85 | KMT2A (1.00) | KMT2AKEAP1MEN1ALDH1A1PKM | |
| SCHEMBL25031372 | 0.85 | KEAP1 (1.00) | KMT2AKEAP1MEN1ALDH1A1PKM | |
| Phenyl(Phenylsulfonyl)Amine SCHEMBL114765 | 0.85 | KEAP1 (1.00) | KMT2AKEAP1MEN1ALDH1A1PKM | |
| Sulfabenzamide SCHEMBL28121834 | 0.84 | KMT2A (0.83) | KMT2AKEAP1MEN1ALDH1A1PKM | |
| SCHEMBL19603195 | 0.84 | CA1 (0.76) | KMT2AKEAP1MEN1ALDH1A1PKM | |
| SCHEMBL28271812 | 0.83 | HTR6 (1.00) | KMT2AKEAP1PKMHTR6CA2 | |
| Phenyl(Phenylsulfonyl)Amine SCHEMBL6399560 | 0.83 | KEAP1 (0.95) | KMT2AKEAP1MEN1ALDH1A1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1682 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026097199-A1 | SINTERABLE BONDING MATERIAL AND SEMICONDUCTOR DEVICE USING THE SAME | HENKEL AG & CO. KGAA (DE) | 2026-05-15 | — | — | WO | claimed |
| CN-118880537-A | Anti-biological adhesion warp knitting net product and preparation method thereof | 山东海工科技有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-118546213-A | Tumor targeting polypeptide and application | 南方医科大学深圳医院 | 2024-08-27 | — | — | CN | claimed |
| CN-111393304-B | Method for preparing p-phenylenediamine from aniline | 江苏扬农化工集团有限公司 | 2023-01-17 | — | — | CN | claimed |
| US-20220169680-A1 | CELL-PENETRATING PEPTIDE BASED ON INFLUENZA VIRUS M2 PROTEIN | INSTITUTE OF BASIC MEDICAL SCIENCES CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2022-06-02 | — | — | US | claimed |
| EP-3912989-A1 | CELL-PENETRATING PEPTIDE BASED ON INFLUENZA VIRUS M2 PROTEIN | Institute of Basic Medical Sciences Chinese Academy of Medical Sciences (CN) | 2021-11-24 | — | — | EP | claimed |
| WO-2021054927-A2 | GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS | SOUTH DAKOTA BOARD OF REGENTS (US) | 2021-03-25 | — | — | WO | claimed |
| CN-111393304-A | Method for preparing p-phenylenediamine from aniline | 江苏扬农化工集团有限公司 | 2020-07-10 | — | — | CN | claimed |
| US-20200048305-A1 | GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS | SOUTH DAKOTA BOARD OF REGENTS (US) | 2020-02-13 | — | — | US | claimed |
| CN-110290790-A | For treating composition, the device and method of obsessive-compulsive disorder | 消化系统疾病中心 | 2019-09-27 | — | — | CN | claimed |
| EP-1054588-A4 | METHOD FOR THE STIMULATION OF SPERM PRODUCTION AND GONADAL DEVELOPMENT IN ANIMALS | UNIV MARYLAND (US) | 2002-09-25 | — | — | EP | claimed |
| EP-1054588-A1 | METHOD FOR THE STIMULATION OF SPERM PRODUCTION AND GONADAL DEVELOPMENT IN ANIMALS | UNIVERSITY OF MARYLAND (US) | 2000-11-29 | — | — | EP | claimed |
| WO-1999038376-A1 | METHOD FOR THE STIMULATION OF SPERM PRODUCTION AND GONADAL DEVELOPMENT IN ANIMALS | UNIVERSITY OF MARYLAND (US) | 1999-08-05 | — | — | WO | claimed |
| EP-0572560-A4 | USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY. | SHAPIRO HOWARD K (US) | 1995-04-26 | — | — | EP | claimed |
| EP-0572560-A1 | USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY | SHAPIRO, Howard, K. (US) | 1993-12-08 | — | — | EP | claimed |
| WO-1992014456-A1 | USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY | SHAPIRO HOWARD K (US) | 1992-09-03 | — | — | WO | claimed |
| EP-0176504-B1 | POLYCARBOXYLIC ACID/BORIC ACID/AMINE SALTS AND AQUEOUS SYSTEMS CONTAINING SAME | The Lubrizol Corporation (US) | 1989-03-22 | — | — | EP | claimed |
| EP-0036292-B1 | PROCESS FOR THE PRODUCTION OF AROMATIC HYDROCARBONS | The British Petroleum Company p.l.c. (GB) | 1985-01-16 | — | — | EP | claimed |
| US-4094976-A | ANTICOCCIDIAL CYCLICAMINO ETHANOLS AND ESTERS THEREOF | MERCK & CO., INC. (US) | 1978-06-13 | — | — | US | claimed |
| US-4011208-A | 3-CYANO OR ACYL-4-ARYL-5-ARYLAZO-6-HYDROXYPYRIDONE-2 DYES | SANDOZ LTD. (CH) | 1977-03-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048305-A1 | GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS | GSTK1, GSTO1, GSTM2 | KMT2A 3630/4885KEAP1 44/4885MEN1 1607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.